Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects
Journal:
Current Pharmacogenomics
Volume:
3
Page:
157-164
Author(s):
Shih-Jen Tsai and Chen-Jee Hong
A Review of Current Drug Targets and Pharmacology of Antipsychotic Treatment
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
2
Page:
177-182
Author(s):
Robert R. Conley and Deanna L. Kelly
2(3H)-Benzoxazolone and Bioisosters as “Privileged Scaffold” in the Design of Pharmacological Probes
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
877-885
Author(s):
Jacques Poupaert, Pascal Carato and Evelina Colacino
The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders
Journal:
Current Drug Metabolism
Volume:
6
Page:
127-139
Author(s):
P. Yogeeswari, D. Sriram and J. Vaigundaragavendran
NOS: Molecular Mechanisms, Clinical Aspects, Therapeutic and Monitoring Approaches
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
141-149
Author(s):
Sergei A. Kharitonov
Inflammatory Process in Parkinsons Disease: Role for Cytokines
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
999-1016
Author(s):
T. Nagatsu and M. Sawada
Role of the 5-HT2C Receptor in Atypical Antipsychotics: Hero or Villain?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
63-66
Author(s):
Martyn Wood
Gene Therapy for Parkinsons Disease: Progress and Challenges
Journal:
Current Gene Therapy
Volume:
5
Page:
71-80
Author(s):
Qin Chen, Yi He and Keyi Yang
Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Journal:
Current Genomics
Volume:
6
Page:
13-37
Author(s):
E. J. Kremer
Adult Neural Stem Cell Therapy: Expansion In Vitro, Tracking In Vivo and Clinical Transplantation
Journal:
Current Drug Targets
Volume:
6
Page:
97-110
Author(s):
J. Zhu, X. Wu and H. L. Zhang